Rekombinanter CRHR2 Antikörper
Kurzübersicht für Rekombinanter CRHR2 Antikörper (ABIN7566415)
Target
Alle CRHR2 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Verwendungszweck
 - anti-Crf2 (Aspergillus fumigatus), mAb (rec.) (MS112-IIA1)
 - 
                                            
Produktmerkmale
 - 
                        
Recombinant Antibody. Recognizes Crf2 from Aspergillus fumigatus. Possible cross-reactivity with Crf1, Crf2 and Asp f9 [Reference 2]. Applications: ELISA, FUNC, IHC, WB, IF. Clone: MS112-IIA1. Isotype: Human IgG1. Formulation: Liquid. In PBS. Aspergillus fumigatus is a common airborne fungal pathogen for humans. It frequently causes an invasive aspergillosis (IA) in immunocompromised patients with poor prognosis. Potent antifungal drugs are very expensive and cause serious adverse effects. Their correct application requires an early and specific diagnosis of IA. Encoded by CRF1 gene, the Crf protein family contains three protein variants: Crf2 protein, amino acids (333 aa) long, Asp f9 protein (292 aa), first identified as an allergen using serum from Aspergillus-allergic patients and Crf1 (395 aa, also named Crh5). The glycosyol hydrolase/glycosidase Crf2 catalyzes the hydrolysis of glycosidic bonds in complex sugars and is located in the cell wall of the growing hyphae. Crf2 may be involved in the remodeling of the cell wall as well, and therefore in the growth and the virulence of the fungus.
Aspergillus fumigatus is a common airborne fungal pathogen for humans. It frequently causes an invasive aspergillosis (IA) in immunocompromised patients with poor prognosis. Potent antifungal drugs are very expensive and cause serious adverse effects. Their correct application requires an early and specific diagnosis of IA. Encoded by CRF1 gene, the Crf protein family contains three protein variants: Crf2 protein, amino acids (333 aa) long, Asp f9 protein (292 aa), first identified as an allergen using serum from Aspergillus-allergic patients and Crf1 (395 aa, also named Crh5). The glycosyol hydrolase/glycosidase Crf2 catalyzes the hydrolysis of glycosidic bonds in complex sugars and is located in the cell wall of the growing hyphae. Crf2 may be involved in the remodeling of the cell wall as well, and therefore in the growth and the virulence of the fungus.
 - 
                                            
Aufreinigung
 - Puified
 - 
                                            
Reinheit
 - >95 % (SDS-PAGE)
 - 
                                            
Immunogen
 - Recombinant Crf2 (Aspergillus fumigatus) containing a C-terminal His-tag.
 - 
                                            
Isotyp
 - IgG1
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 1 mg/mL
 - 
                                            
Buffer
 - In PBS.
 - 
                                            
Handhabung
 - After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.Please handle under sterile conditions to avoid contamination.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - 
                        
Stable for at least 1 year after receipt when stored at -20°C.
Stable for at least 1 week when stored at +4°C.
 
 - 
                                            
 - 
    
- CRHR2 (Corticotropin Releasing Hormone Receptor 2 (CRHR2))
 - 
                                            
Andere Bezeichnung
 - Crf2
 - 
                                            
UniProt
 - Q4WI46
 - 
                                            
Pathways
 - Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Feeding Behaviour
 
Target
 -